Thymosin alpha-1 (TA1)—often used in its synthetic form known as thymalfasin—is a 28-amino-acid peptide naturally produced by the thymus gland. Rather than simply over-stimulating the immune system, it acts as an immune modulator to help balance, restore, and optimize immune function
Primary Benefits and Clinical Uses
Immune System Modulation & Enhancement:
Stimulates the maturation and function of T-cells (crucial for identifying and neutralizing infected or abnormal cells).
Enhances the activity of natural killer (NK) cells, dendritic cells, and macrophages.
Helps balance helper T-cell responses (Th1/Th2) and regulatory T-cells (Tregs) to control excessive inflammation.
Support for Viral Infections:
Used as an adjunctive treatment in chronic viral infections such as Hepatitis B (HBV) and Hepatitis C (HCV), as well as investigated in HIV and acute or post-acute viral states (like long COVID/post-viral fatigue).
Oncology & Chemotherapy Support:
Studied and utilized in certain cancers (such as hepatocellular carcinoma, renal cell carcinoma, and non-small cell lung cancer).
Helps decrease chemotherapy-induced toxicity and can act synergistically with cancer therapies to improve anti-tumor immune surveillance

